Anti-PCSK9 Antibody (Frovocimab)
Catalog No.
F1455
Anti-PCSK9 Antibody (Frovocimab)
Featured Products
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits the binding of PCSK9 to the LDL receptor (LDLR) while allowing the bound intact PCSK9 to undergo normal proteolytic cleavage.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1643672-70-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Frovocimab (USAN), LY-3015014, LY3015014
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q8NBP7
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
PCSK9
Please avoid freeze-thaw cycles.